Possible substitution of aspirin by P2Y12 inhibitor monotherapy one year after PCI
5' education - May 16, 2021 - Prof. Freek Verheugt, MD - Amsterdam, The NetherlandsEducational information
This video was recorded during the virtual congress of the ACC.21.
Faculty
Prof. Verheugt - cardioloog in Amsterdam, The Netherlands.
Disclosures
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: